Brighthouse Financial
BHF · Life & Health Insurance
$45.41
2.0%Rocket Companies
RKT · Commercial & Residential Mortgage Finance
$11.73
0.1%The short version
- Brighthouse Financial is the larger business, with $6.8B of revenue in fiscal 2025 against $6.7B for Rocket Companies.
- Brighthouse Financial grew revenue faster (43.2%, against 31.3%).
| Latest fiscal year | BHF · FY25 | RKT · FY25 |
|---|---|---|
| Size | ||
| Market cap | $2.6B | $33.4B |
| Revenue | $6.8B | $6.7B |
| Free cash flow | — | −$4.0B |
| Net income | $433M | −$68.0M |
| Growth | ||
| Revenue growth | 43.2% | 31.3% |
| 5-year growth | −4.5% | −15.6% |
| Share count change | −5.9% | 837.6% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | 6.4% | −1.0% |
| FCF margin | — | −60.0% |
| Return on capital | — | — |
| Return on equity | — | −0.4% |
| Balance sheet | ||
| Net debt | −$3.4B | — |
| Net debt / EBITDA | — | — |
| Dividends and buybacks | $102M | $0.0M |
| Valuation & quality | ||
| P/E | 3.6x | — |
| Piotroski F-score | — | — |
FY16
BHF $3.0B
RKT —
FY17
BHF $6.8B
RKT —
FY18
BHF $9.0B
RKT $4.2B
FY19
BHF $6.6B
RKT $5.1B
FY20
BHF $8.5B
RKT $15.7B
FY21
BHF $5.0B
RKT $12.9B
FY22
BHF $6.9B
RKT $5.8B
FY23
BHF $4.1B
RKT $3.8B
FY24
BHF $4.7B
RKT $5.1B
FY25
BHF $6.8B
RKT $6.7B
BHF
RKT
FY16
BHF —
RKT —
FY17
BHF —
RKT —
FY18
BHF —
RKT —
FY19
BHF —
RKT —
FY20
BHF —
RKT —
FY21
BHF —
RKT —
FY22
BHF —
RKT —
FY23
BHF —
RKT —
FY24
BHF —
RKT —
FY25
BHF —
RKT —
BHF
RKT
FY16
BHF —
RKT —
FY17
BHF —
RKT —
FY18
BHF —
RKT $1.4B
FY19
BHF —
RKT −$7.0B
FY20
BHF —
RKT −$1.8B
FY21
BHF —
RKT $7.6B
FY22
BHF —
RKT $10.7B
FY23
BHF —
RKT $51.0M
FY24
BHF —
RKT −$2.7B
FY25
BHF —
RKT −$4.0B
BHF
RKT
FY16
BHF —
RKT —
FY17
BHF —
RKT —
FY18
BHF —
RKT —
FY19
BHF —
RKT —
FY20
BHF —
RKT —
FY21
BHF —
RKT —
FY22
BHF —
RKT —
FY23
BHF —
RKT —
FY24
BHF —
RKT —
FY25
BHF —
RKT —
BHF
RKT
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.